Issue 11 jun 2018 Special Report Gut microbiota, a controllable factor in liver diseases

Numéro 11 - Gut microbiota, a controllable factor in liver diseases
Download for free

The story of the liver… Every minute of our lives, the liver receives 1 litre of blood from the gastrointestinal tract via the portal vein. This blood contains almost all the nutrients absorbed in the intestine, as well as a considerable quantity of metabolites produced by the bacteria of the gut microbiota.

It is therefore reasonable to think that after the intestine, the liver is the organ most affected by this microbiota’s activity. However, while the gut-liver axis has been identified and studied for decades, it is only recently that the microbial aspect has been considered. Now, as this issue’s special report shows, a growing number of studies have proven the gut microbiota's contribution to liver diseases such as metabolic steatosis, alcoholic liver disease and even viral hepatitises.

Therefore, while the gut microbiota may not be their cause, it could explain why we are not all equal when it comes to the risk of developing these diseases. The interview with Dr. Sophie Leclercq expands this view to a microbiotagut- liver-brain axis emphasising, if this is still indeed necessary, the gut bacteria’s ability to remotely influence how certain organs function. The liver and brain are considered vital organs of the human body. But what if they depend partly on our precious bacteria to function properly? Once again, we encourage you to look after your microbiota.

I hope you enjoy reading this issue.

Read more

Table of contents

Special Report

  • Gut microbiota, a controllable factor in liver diseasesPhilippe Gérard, Gabriel Perlemuter, Anne-Marie-Cassard

Microbioto News

  • Archaea: a new generation of probiotics ?Bruno Pot
  • Ispaghula: an adjunct treatment for gastroesophageal reflux ?
  • L. fermentum: a therapeutic alternative in the treatment of vulvovaginal candidiasis ?
  • Probiotic prescriptions in children with acute gastroenteritis: according to a practitioner survey
  • Secondary progressive multiple sclerosis: faecal transplantation which stops the disease's progression

The Microbiota Chronicle

Interview

  • Sophie Leclercq

In Brief

Focus

Taxonomic Reference

Contributors

Dossier thématiqueProf. Gabriel Perlemuter (1,2,3) / Dr. Anne-Marie Cassard (1,2)

1. INSERM UMRS U996 - Inflammation, Cytokines and Immunopathology, DHU Hepatinov, Labex LERMIT, F-92140 Clamart, France. 2. Univ Paris-Sud, Université Paris-Saclay, F-92140, Clamart, France. 3. AP-HP, Hepatogastroenterology and Nutrition, Hôpital Antoine-Béclère, Clamart, France.

EntretienDr. Sophie Leclercq

PhD, FNRS Post-doctoral researcher, Institute of Neuroscience (IONS) and Louvain Drug Research Institute (LDRI) Université Catholique de Louvain

Close

LoginFor free access to all issues & a notification upon publication of each new issue

Forgotten password ?

Password requestHave you forgotten your password? Enter your email address and we will send you a message with the password reset procedure.

Login

Not yet registered ?

Create an account free of charge

Create an accountFor free access to all issues & a notification upon publication of each new issue

If you wish to subscribe to the paper version of La Revue des Microbiotes and have it delivered to your door, please contact our Subscription Department: contact@microbiotes.com.

  • ?
  • As a result, I accept that my email address will be forwarded to the company PILEJE (SAS – French simplified joint stock company – with a capital of €1,190,400,00 - registered at the companies register in Paris under the number 950 450 452 – 37, Quai de Grenelle, 75738 PARIS Cedex 15)

The information included in this form is intended for the company LARENA, responsible for processing, for the purposes of processing your request and managing our relationship.

In accordance with French law no. 78-17 of 6 January 1978, as amended, and European Regulation 2016/679 of 27 April 2016, you have the right to access, correct, restrict or delete data concerning you or exercise your right to opposition or right to portability. You can exercise these rights by making a request in writing, accompanied by proof of identity, to LARENA – DPO Mr Christophe Guyomar – 1 ZI du Taillis – Champtoceaux – 49270 Orée d’Anjou, France or to dpo@larenasante.com.

For more information about the management of your personal data

*These fields are required to process your request. Without this information, we will be unable to process your request .

Already registered

Login

Sample copyAccess the first issue free of charge without creating an account

Numéro 1 - Microorganisms and mankind